Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flora Peyvandi

Showing results (181-190 of 610) with videos related to

Pageof 61
Sort By:
Research and Practice in Thrombosis and Haemostasis|July 9, 2026
Differential expression of miR-128 in memory T cells of patients with severe hemophilia A with and without inhibitorsSilvia Spena, Andrea Cairo, Emanuela Pappalardo, et al.
British Journal of Haematology|April 11, 2016
Pregnancy loss and risk of ischaemic stroke and myocardial infarctionAlberto Maino, Bob Siegerink, Ale Algra, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2019
Risk of diagnostic delay in congenital thrombotic thrombocytopenic purpuraBarbara Ferrari, Andrea Cairo, Maria Teresa Pagliari, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 9, 2013
Comparison of thrombin generation assay with conventional coagulation tests in evaluation of bleeding risk in patients with rare bleeding disordersOmid R Zekavat, Sezaneh Haghpanah, Javad Dehghani, et al.
Blood|October 24, 2002
Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bbeta-chain gene causing activation of cryptic splice sitesSilvia Spena, Stefano Duga, Rosanna Asselta, et al.
Journal of Thrombosis and Haemostasis : JTH|March 3, 2020
Laboratory testing in hemophilia: Impact of factor and non-factor replacement therapy on coagulation assaysFlora Peyvandi, Gili Kenet, Isabell Pekrul, et al.
Blood Advances|October 23, 2023
Minimum factor VIII levels to prevent joint bleeding in mild hemophilia APasquale Agosti, Simona Maria Siboni, Sara Scardo, et al.
Thrombosis Research|October 11, 2014
A two-step approach (Enzyme-linked immunosorbent assay and confirmation assay) to detect antibodies against von Willebrand factor in patients with Acquired von Willebrand SyndromeFranca Franchi, Eugenia Biguzzi, Francesca Stufano, et al.
Blood Transfusion = Trasfusione Del Sangue|February 16, 2023
Flow-chamber device (T-TAS) to diagnose patients suspected of platelet function defectsAnna Lecchi, Silvia La Marca, Lidia Padovan, et al.
Blood|August 1, 2002
Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotypeSepideh Akhavan, Raimondo De Cristofaro, Flora Peyvandi, et al.
Pageof 61

Showing results (181-190 of 610) with videos related to

Sort By:
Pageof 61
Research and Practice in Thrombosis and Haemostasis|July 9, 2026
Differential expression of miR-128 in memory T cells of patients with severe hemophilia A with and without inhibitorsSilvia Spena, Andrea Cairo, Emanuela Pappalardo, et al.
British Journal of Haematology|April 11, 2016
Pregnancy loss and risk of ischaemic stroke and myocardial infarctionAlberto Maino, Bob Siegerink, Ale Algra, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2019
Risk of diagnostic delay in congenital thrombotic thrombocytopenic purpuraBarbara Ferrari, Andrea Cairo, Maria Teresa Pagliari, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 9, 2013
Comparison of thrombin generation assay with conventional coagulation tests in evaluation of bleeding risk in patients with rare bleeding disordersOmid R Zekavat, Sezaneh Haghpanah, Javad Dehghani, et al.
Blood|October 24, 2002
Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bbeta-chain gene causing activation of cryptic splice sitesSilvia Spena, Stefano Duga, Rosanna Asselta, et al.
Journal of Thrombosis and Haemostasis : JTH|March 3, 2020
Laboratory testing in hemophilia: Impact of factor and non-factor replacement therapy on coagulation assaysFlora Peyvandi, Gili Kenet, Isabell Pekrul, et al.
Blood Advances|October 23, 2023
Minimum factor VIII levels to prevent joint bleeding in mild hemophilia APasquale Agosti, Simona Maria Siboni, Sara Scardo, et al.
Thrombosis Research|October 11, 2014
A two-step approach (Enzyme-linked immunosorbent assay and confirmation assay) to detect antibodies against von Willebrand factor in patients with Acquired von Willebrand SyndromeFranca Franchi, Eugenia Biguzzi, Francesca Stufano, et al.
Blood Transfusion = Trasfusione Del Sangue|February 16, 2023
Flow-chamber device (T-TAS) to diagnose patients suspected of platelet function defectsAnna Lecchi, Silvia La Marca, Lidia Padovan, et al.
Blood|August 1, 2002
Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotypeSepideh Akhavan, Raimondo De Cristofaro, Flora Peyvandi, et al.
Pageof 61